Volume 2, Issue 2, June 2023

					View Volume 2, Issue 2, June 2023
  • Review: Coronavirus disease (COVID-19) in patients with hematologic malignancy
  • Cellular therapy in CLL/iNHL: Therapeutic agents in the pipeline
  • Evolving role of novel therapies in myeloma: T-cell engagers and antibody-drug conjugates
  • Acute myeloid leukemia induction in the age of novel therapeutic agents
  • Initiating venetoclax treatment: Clinical practice pearls
Published: 2023-06-07